Tarik Asselah

2 ta ish

University of Paris

1. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study

   Devin Razavi‐Shearer, Ivane Gamkrelidze, Calvin Q. Pan +97

   Maqola20235 iqtibos

   ABIABI:AkademIndex/2026.other.419454

2. Number of people treated for hepatitis C virus infection in 2014-2023 and applicable lessons for new HBV and HDV therapies

   Homie Razavi, Imam Waked, Huma Qureshi +97

   MaqolaOAOchiq kirishHepatitis C virus researchJournal of Hepatology20250 iqtibos

   ABIABI:AkademIndex/2025.article.000135